On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.

CannabisNewsBreaks – Outlier Biopharma Inc. to Open State-of-the-Art Extraction Plant in the Caribbean

Company: Outlier Biopharma Inc.
Category: News

Outlier Biopharma, one of Jamaica’s newest cannabis agro-processing, research, development, manufacturing and distribution companies, is making waves within the local and international cannabis industries. The company today announced the upcoming opening of its state-of-the-art extraction plant, which will be one of the largest of its kind in the Caribbean. The facility is scheduled to commence operations in April 2021 and will see Outlier Biopharma extracting full-spectrum oils from cannabis plants to produce products for the global medical cannabis research market. In addition to cannabis, the facility has the ability to extract from other botanicals, a move that will expand Jamaica’s agro-processing capabilities and provide additional opportunities within the cannabis industry and the wider agriculture sector. “We are very excited about the opportunities that will come on stream from the opening of our extraction lab,” said Brian Thelwell, managing director of Outlier Biopharma. “Not only will we be extracting and exporting cannabis and botanical oils globally, but we also have a number of partnerships in the works which will push the boundaries of medical cannabis innovation, research and development.”

To view the full press release, visit https://cnw.fm/vqCAA

About Outlier Biopharma Inc.

Outlier Biopharma is a vertically integrated biotechnology company focusing on research, development, manufacturing, and distribution of cannabis and cannabinoid-based products. Outlier Biopharma’s operations are based in Montego Bay, Jamaica, where the company provides outsourced cannabis solutions for various sized cannabis businesses. For more information, please visit www.OutlierBiopharma.com.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

Official NewsWire Relationships

Benzinga Cannabis Capital Conference Cannabis Business Summit & Expo 2019 Cannabis Drinks Expo Cannabis World Congress & Business Exposition MjMicro Conference New England Cannabis Network O'Cannabiz Conference & Expo USA CBD Expo

CannabisNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 303.498.7722